(Q41648536)

6 October 2017

1 reference

title

Free radicals and antioxidants in chemotherapy-induced toxicity (English)

1 reference

6 October 2017

1 reference

Weijl NI

1

1 reference

6 October 2017

Cleton FJ

series ordinal

2

1 reference

6 October 2017

Osanto S

series ordinal

3

1 reference

6 October 2017

language of work or name

1 reference

1 July 1997

1 reference

6 October 2017

Cancer Treatment Reviews

1 reference

6 October 2017

23

1 reference

6 October 2017

4

1 reference

6 October 2017

209-240

1 reference

Glutathione and detoxification

6 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Oxygen free radicals and metallothionein

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Metallothionein induction by sodium selenite at two different ambient temperatures in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Ascorbic acid-selenite interactions in humans studied with an oral dose of 74SeO3(2-)

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Preventive and therapeutic effects of thiamine, ascorbic acid and their combination in lead intoxication.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Dietary supplements of vitamin E, beta-carotene, coenzyme Q10 and selenium protect tissues against lipid peroxidation in rat tissue slices

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Effect of vitamin E on the balance between pro- and antioxidant activity of ascorbic acid in microsomes from rat heart, kidney and liver.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Serum retinol, beta-carotene, vitamin E, and selenium as related to subsequent cancer of specific sites

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Lipid peroxides in the polychemotherapy of cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

5-Hydroxymethyluracil excretion, plasma TBARS and plasma antioxidant vitamins in adriamycin-treated patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Lipid peroxidation products, and vitamin and trace element status in patients with cancer before and after chemotherapy, including adriamycin. A preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Effects of anthracyclin-based chemotherapy on total plasma antioxidant capacity in small cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Plasma vitamin E and beta-carotene concentrations during radiochemotherapy preceding bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Effect of etoposide (VP16-213) on lipid peroxidation and antioxidant status in a high-dose radiochemotherapy regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Presence of iron catalytic for free radical reactions in patients undergoing chemotherapy: implications for therapeutic management

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Bleomycin-detectable iron in serum from leukaemic patients before and after chemotherapy. Therapeutic implications for treatment with oxidant-generating drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Bleomycin-reactive iron in patients with acute non-lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Effect of coadministration of selenite on the toxicity and antitumor activity of cis-diamminedichloroplatinum (II) given repeatedly to mice

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Ascorbic acid and adriamycin toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Randomized placebo-controlled multicenter evaluation of diethyldithiocarbamate for chemoprotection against cisplatin-induced toxicities

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Combined effects of vitamin E (alpha-tocopherol) and cisplatin on the growth of murine neuroblastoma in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Modification of the effect of tamoxifen, cis-platin, DTIC, and interferon-alpha 2b on human melanoma cells in culture by a mixture of vitamins

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung-cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Mechanisms of bleomycin-induced lung damage

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Prevention of doxorubicin-induced killing of MCF-7 human breast cancer cells by oxygen radical scavengers and iron chelating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Depletion of cellular iron by bps and ascorbate: effect on toxicity of adriamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Cisplatin generates superoxide anion by interaction with DNA in a cell-free system

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Interactions of platinum complexes with thioltransferase(glutaredoxin), in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Increased release of hydrogen peroxide (H2O2) and superoxide anion (O-2) by murine macrophages in vitro after cis-platin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Indication of reduced doxorubicin-induced cardiac toxicity by additional treatment with antioxidative substances

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

The effects of α-tocopherol on the toxicity, disposition, and metabolism of adriamycin in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

The effect of vitamin E and selenium on doxorubicin (Adriamycin) induced delayed toxicity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Amelioration of adriamycin-induced cardiotoxicity in rabbits by prenylamine and vitamins A and E

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Acute cardiac toxicity in patients after doxorubicin treatment and the effect of combined tocopherol and nifedipine pretreatment

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Clinical and pharmacologic investigation of the effects of alpha-tocopherol on adriamycin cardiotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Selenium supplementation decreases the pro-oxidant and cardiotoxicity effects of adriamycin in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

The influence of selenium intake on chronic adriamycin toxicity and lipid peroxidation in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Protective effect of dietary selenium supplementation on delayed cardiotoxicity of adriamycin in rat: is PHGPX but not GPX involved?

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Usefulness of a free radical scavenger in preventing doxorubicin-induced heart failure in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Effect of sulfhydryl-containing compounds on the antitumor effects of adriamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Protective effect of endogenous coenzyme Q on both lipid peroxidation and respiratory chain inactivation induced by an adriamycin-iron complex

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Inhibition by adriamycin of the mitochondrial biosynthesis of coenzyme Q10 and implication for the cardiotoxicity of adriamycin in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Inhibition of coenzyme Q10-enzymes, succinoxidase and NADH-oxidase, by adriamycin and other quinones having antitumor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

A protective effect of coenzyme Q10 on the adriamycin-induced cardiotoxicity in the isolated perfused rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Possible prevention from the progression of cardiotoxicity in adriamycin-treated rabbits by coenzyme Q10

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Prevention of anthracycline cardiotoxicity by iron chelation

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Prevention of doxorubicin-induced myocardial and haematological toxicities in rats by the iron chelator desferrioxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Reduction of daunomycin toxicity by razoxane

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Inhibition of cardiotoxic, nephrotoxic and neurotoxic effects of doxorubicin by ICRF-159

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

ICRF-187 permits longer treatment with doxorubicin in women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

The dioxopiperazine derivatives, their leukemogenic potential and other biological effects

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Specific chromosome changes and nonoccupational exposure to potentially carcinogenic agents in acute leukemia in China

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Specific chromosomal translocations and therapy-related leukemia induced by bimolane therapy for psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Randomized trial of oral adjuvant razoxane (ICRF 159) in resectable colorectal cancer: five-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Acute myeloid leukaemia after treatment with razoxane

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Doxorubicin-induced hair loss in the Angora rabbit: a study of treatments to protect against the hair loss

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Failure of high-dose tocopherol to prevent alopecia induced by doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Cisplatin nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Cisplatin nephrotoxicity. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Adverse effects of anti-tumor drug, cisplatin, on rat kidney mitochondria: disturbances in glutathione peroxidase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Iron- and ascorbic acid-induced lipid peroxidation in renal microsomes isolated from rats treated with platinum compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Acute and long-term nephrotoxicity of cis-platinum in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Chronic renal magnesium loss, hypocalciuria and mild hypokalaemic metabolic alkalosis after cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Effects of magnesium supplementation in testicular cancer patients receiving cis-platin: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Severe vascular toxicity associated with cisplatin-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Effects of chronic protein-calorie malnutrition on the kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Kidney injury induced by lipid peroxide produced by vitamin E deficiency and GSH depletion in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Induction of renal growth and injury in the intact rat kidney by dietary deficiency of antioxidants

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Effect of vitamins C and E on toxicity and mutagenicity of hexavalent chromium in rat and guinea pig.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Influence of thiamine and ascorbic acid supplementation on the antidotal efficacy of thiol chelators in experimental lead intoxication

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

The influence of ascorbic acid on lipid peroxidation in guinea pigs intoxicated with cadmium

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

The role of glutathione in the acute nephrotoxicity of sodium dichromate

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Selenium concentration and glutathione peroxidase activity in selenium and magnesium deficient rats

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Amelioration by Ascorbic Acid of Cisplatin-Induced Injury in Cultured Renal Epithelial Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Modification of cisplatin toxicity by antioxidants

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Failure of a 21-Aminosteroid Antioxidant to Ameliorate Cisplatin-Induced Nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Effect of desferrioxamine on cisplatin-induced nephrotoxicity in normal rats

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Modification of cisplatin-induced renal p-aminohippurate uptake alteration and lipid peroxidation by thiols, Ginkgo biloba extract, deferoxamine and torbafylline

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

The mechanism of interaction between cisplatin and selenite

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Effects of Various Dietary Levels of Selenium as Selenite or Selenomethionine on Tissue Selenium Levels and Glutathione Peroxidase Activity in Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Effect of chemical form of selenium on tissue glutathione peroxidase activity in developing rats

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Deficiency of selenium intake enhances manifestation of renal toxicity of cis-diamminedichloroplatinum in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

The effects of co-administration of selenium and cis-platin (CDDP) on CDDP-induced toxicity and antitumour activity

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Effect of bismuth nitrate given in combination with cis-diamminedichloroplatinum(II) on the antitumor activity and renal toxicity of the latter in nude mice inoculated with human bladder tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

The role of metallothionein in the reduction of cisplatin-induced nephrotoxicity by Bi3(+)-pretreatment in the rat in vivo and in vitro. Are antioxidant properties of metallothionein more relevant than platinum binding?

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Can bismuth decrease the kidney toxic effect of cis-platinum?

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Mechanism of the increase in lipid peroxide induced by cisplatin in the kidneys of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Role of glutathione for cisplatin nephrotoxicity in young and adult rats

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Increases in urinary enzyme excretion in rats depleted of glutathione inhibited by scavenger of oxygen free radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Beneficial effect of acetylcysteine on cisplatin nephrotoxicity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

The role of glutathione in combination with cisplatin in the treatment of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

High-dose cisplatin and cyclophosphamide with glutathione in the treatment of advanced ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Phase I trial of cisplatin in combination with glutathione

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyldithiocarbamate, but not mesna

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Modification of cisplatin toxicity with diethyldithiocarbamate.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Amifostine, cisplatin, and vinblastine in metastatic non-small-cell lung cancer: a report of high response rates and prolonged survival

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Drugs five years later. Cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Mechanism of cisplatin ototoxicity: antioxidant system.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Mechanism of Protection by Diethyldithiocarbamate against Cisplatin Ototoxicity: Antioxidant System

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Diet is a risk factor in cisplatin ototoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Effects of cisplatin and thiosulfate upon auditory brainstem responses of guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

A randomised double-blind placebo controlled clinical trial assessing the tolerability and efficacy of glutathione as an adjuvant to escalating doses of cisplatin in the treatment of advanced ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Cisplatin neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Neurotoxicity is not enhanced by increased dose intensities of cisplatin administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Cisplatin-induced peripheral neuropathy. Frequent off-therapy deterioration, demyelinating syndromes, and muscle cramps

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Protective effects of glutathione on cisplatin neurotoxicity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

The control of chemotherapy-induced emesis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Alterations in pulmonary protective enzymes following systemic bleomycin treatment in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

A molecular basis for bleomycin-induced pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Effect of oxygen concentration on pulmonary fibrosis caused by peplomycin in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Direct toxic effect of bleomycin on alveolar type 2 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Reduction in bleomycin-induced lung hydroxyproline content by an iron chelating agent

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Effect of iron deficiency on bleomycin-induced lung fibrosis in the hamster

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Deferoxamine infusion does not inhibit bleomycin-induced lung damage in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

ICRF 187 and polyhydroxyphenyl derivatives fail to protect against bleomycin induced lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Morphologic and morphometric evaluation of the effect of ICRF-187 on bleomycin-induced pulmonary toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Effects of the 21-aminosteroid, U74389F, on bleomycin-induced pulmonary fibrosis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Inhibition of bleomycin lung toxicity by N-acetyl cysteine in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Interaction of N-acetylcysteine and bleomycin on hyperbaric oxygen-induced lung damage in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Inhibitory effects of the dietary antioxidants butylated hydroxyanisole and butylated hydroxytoluene on bronchioloalveolar cell proliferation during the bleomycin-induced pulmonary fibrosing process in hamsters

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Taurine protection of lungs in hamster models of oxidant injury: a morphologic time study of paraquat and bleomycin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Increased microsomal irreversible binding of phenytoin by valproic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Vitamin E reduces bleomycin-induced lung fibrosis in mice: biochemical and morphological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Effects of vitamin E deficiency on bleomycin-induced pulmonary fibrosis in the hamster

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Oral health care for the cancer patient

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

The modifying effect of beta-carotene on radiation and chemotherapy induced oral mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Prophylaxis of oral mucositis associated with chemoradiotherapy for oral carcinoma by Azelastine hydrochloride (Azelastine) with other antioxidants

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Vitamin E in the treatment of chemotherapy-induced mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Protective effect of doxorubicin in vitamin C or dimethyl sulfoxide against skin ulceration in the pig

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Treatment of tissue extravasation by antitumor agents

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Etiology and treatment of chemotherapeutic agent extravasation injuries: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Prevention of cytotoxic drug induced skin ulcers with dimethyl sulfoxide (DMSO) and alpha-tocopherole

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Myeloid neoplasia in children treated for solid tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Oxidative mechanisms in carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Cytotoxicity and genotoxicity of lipid-oxidation products

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Frequencies of HPRT mutants and micronuclei in lymphocytes of cancer patients under chemotherapy: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Increased frequency of chromosomal damage in peripheral blood lymphocytes up to nine years following curative chemotherapy of patients with testicular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Inhibition of mitomycin C-induced sister chromatid exchanges by vitamin C in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Inhibition of adriamycin-induced micronuclei by desferrioxamine in Swiss albino mice

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Effect of ascorbate on adriamycin-Fe(3+)-induced lipid peroxidation and DNA damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

cis-diamminedichloroplatinum(II)-induced sister-chromatid exchanges and chromosome aberration formation in cultured human lymphocytes and their inhibition by sodium thiosulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Sodium thiosulfate inhibits cisplatin-induced mutagenesis in somatic tissue of Drosophila.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Effect of preinduction of metallothionein synthesis on clastogenicity of anticancer drugs in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Modifications of the effect of bleomycin in the somatic mutation and recombination test in Drosophila melanogaster.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Correlation between the anti-oxidant enzyme activities of blood fractions and the yield of bleomycin-induced chromosome damage

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Inhibition of the genotoxicity of bleomycin by superoxide dismutase

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

The effect of various antioxidants and other modifying agents on oxygen-radical-generated DNA damage in human lymphocytes in the COMET assay

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Effects of N-acetyl-l-cysteine and ascorbic acid on mutagen-induced chromosomal sensitivity in patients with head and neck cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

The effect of antioxidants on bleomycin treatment in in vitro and in vivo genotoxicity assays.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Antioxidant and pro-oxidant actions of the plant phenolics quercetin, gossypol and myricetin. Effects on lipid peroxidation, hydroxyl radical generation and bleomycin-dependent damage to DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Effect of beta-carotene on clastogenic effects of mitomycin C, methyl methanesulphonate and bleomycin in Chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Influence of the antioxidant N-acetylcysteine and its metabolites on damage induced by bleomycin in PM2 bacteriophage DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Myelodysplastic syndrome after cisplatin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Secondary neoplasms following treatment of malignant germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Treatment of testicular cancer and the development of secondary malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

New concepts in the biology and biochemistry of ascorbic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Suncus murinus: a new experimental model in emesis research

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

Characterization of drugs as antioxidant prophylactics

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990012-8

7 January 2021

10.1016/S0305-7372(97)90012-8

Identifiers

DOI

1 reference

6 October 2017

1 reference